Interventions that address socioeconomic determinants of health are receiving considerable attention from policy makers and health care executives. The interest is fueled in part by expected returns ...
Only 2-5% of all US patients are enrolled in a clinical trial. At the same time, at least 85% of clinical trials fail to meet their recruitment goals, nearly half under-enrol patients, and a striking ...
Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.